Biotech

All Articles

ArsenalBio elevates $325M, pivots off of former lead property

.Collection Biosciences is carrying on up. The tissue treatment company has actually added on $325 t...

Lilly- backed weight loss biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' cannabis use drug fails stage 2b, steering Indivior to reconsider $100M choice

.Aelis Farma's chances of getting a simple, good choice on a $one hundred thousand option settlement...

ProKidney standstills period 3 trial certainly not required for cell therapy permission

.ProKidney has ceased among a set of period 3 tests for its own cell therapy for renal health condit...

Vaxcyte climbs on 'sensational' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what experts called "stunning" stage 1/2 records for its own 31-valent pneumococ...

Recursion's brain health condition test reveals insufficient proof of efficacy

.Recursion has stumbled via a very early test of its own tech-enabled strategy to drug discovery, st...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Phone it a scenario of good chemistry: Acepodia, a biotech based on Nobel Champion scientific resea...

Praxis epilepsy medication lowers seizures in phase 2 trial

.Praxis Preciseness Medicines has actually scored one more midphase win in epilepsy this year, with ...

Three execs resign as Dyne posts blended information for DMD prospect

.After leaving a clinical grip several years back, Dyne Therapy has actually disclosed brand-new pha...

Arrowhead fires off period 3 records in unusual metabolic condition in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its hand in advance of a prospective face-off along with Ionis,...